Comprehensive analysis of the TGF-β signaling pathway: molecular mechanisms, disease drivers, and frontiers in clinical translation - Top-Institutions - MDSpire

Comprehensive analysis of the TGF-β signaling pathway: molecular mechanisms, disease drivers, and frontiers in clinical translation

  • By

  • Yiting Zhang

  • Haixia Tang

  • Ze Zhou

  • Jiabao Liao

  • Xiaoyu Zhou

  • Xin Chu

  • Mengqiu Shao

  • Caiyan Zhang

  • Lijuan Jiang

  • June 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Cancer Care
    • Molecular Biology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Cancer Care
    • Molecular Biology

  • #3

    University Medical Center Utrecht
    University Medical Center Utrecht

    Utrecht, Utrecht

    Key Differentiators

    • Molecular Biology

  • #4

    Medical University of Gdańsk
    Medical University of Gdańsk

    Gdańsk, Pomeranian Voivodeship

    Key Differentiators

    • Pediatric Gastroenterology

  • #5

    Kings College Hospital NHS Foundation Trust
    Kings College Hospital NHS Foundation Trust

    London, England

    Key Differentiators

    • Molecular Biology

Original Source(s)

Comprehensive analysis of the TGF-β signaling pathway: molecular mechanisms, disease drivers, and frontiers in clinical translation

  • by Yiting Zhang, Haixia Tang, Ze Zhou, Jiabao Liao, Xiaoyu Zhou, Xin Chu, Mengqiu Shao, Caiyan Zhang, Lijuan Jiang

  • June 4, 2026

Related Content

Disseminated hepatic epithelioid hemangioendothelioma with multiorgan metastases achieving long-term stability with Pazopanib: a case report

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma